I.
General Considerations (Non organ specific) In Gastroenterology
A. Inflammatory Bowel Disease
Predicting a Change in Diagnosis From Ulcerative Colitis to Crohn's Disease
Rakesh Chaudhary, MBBS, MRCP
Excess Hospitalisation Burden Associated with Clostridium Difficile in Patients with Inflammatory Bowel Disease
Siew Ng, MBBS, MRCP , 27 Nov 2007
Predicting a Change in Diagnosis From Ulcerative Colitis to Crohn's Disease
Rakesh Chaudhary, MBBS, MRCP
Excess Hospitalisation Burden Associated with Clostridium Difficile in Patients with Inflammatory Bowel Disease
Siew Ng, MBBS, MRCP , 27 Nov 2007
1. Pathophysiology of IBD
Pathology of Inflammatory Bowel Disease
Gregory Y. Lauwers, M.D.
Stress in IBD
Joshua R. Korzenik, M.D. , 18 Jan 2007
Pathology of Inflammatory Bowel Disease
Gregory Y. Lauwers, M.D.
Stress in IBD
Joshua R. Korzenik, M.D. , 18 Jan 2007
2. Genetics of IBD
3. Intestinal and nonintestinal manifestations of IBD
Ocular Manifestations of Inflammatory Bowel Disease
George N. Papaliodis, M.D.
Nodular Regenerative Hyperplasia in Patients with Inflammatory Bowel Disease Treated with Azathioprine
Jeremy Nightingale, MD , 12 Oct 2007
Ocular Manifestations of Inflammatory Bowel Disease
George N. Papaliodis, M.D.
Nodular Regenerative Hyperplasia in Patients with Inflammatory Bowel Disease Treated with Azathioprine
Jeremy Nightingale, MD , 12 Oct 2007
4. IBD in pregnancy
Fertility and Pregnancy in Inflammatory Bowel Disease
Sonia Friedman, M.D.
Controversies in the Medical Management of IBD
Stephen B. Hanauer, M.D. , 29 Nov 2005
Fertility and Pregnancy in Inflammatory Bowel Disease
Sonia Friedman, M.D.
Stephen B. Hanauer, M.D. , 29 Nov 2005
5. Advances in IBD treatment
Infliximab prevents Crohn's Disease Recurrence After Ileal Resection
Dr. J Macnaughtan
Therapy of Metronidazole with Azathioprine to prevent postoperative recurrence of Crohn's Disease
Dr. J Macnaughtan
Mortality in Patients with and without Colectomy Admitted to Hospital for UC and Crohn's Disease
Aravinth Murugananthan, MBBS, MRCP , 27 Nov 2007
Cases from the Bigelow
Kathleen Corey, MD, MPH
Effect of Allopurinol on Clinical Outcomes in Inflammatory Bowel Disease Non-Reponders to Azathioprine and 6-Mercaptopurine
Stephen Goldfinger, M.D. , 05 Apr 2007
MMX Mesalamine in Active Ulcerative Colitis
Deanna D. Nguyen, M.D.
A Review of The CHARM Trial
Gilaad G. Kaplan, MD, MPH
The Role of the Environment in IBD
Joel V. Weinstock, M.D.
TNF-a Inhibitors in IBD
Adam S. Cheifetz, M.D.
Human anti-Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease
Deanna D. Nguyen, M.D.
Infliximab prevents Crohn's Disease Recurrence After Ileal Resection
Dr. J Macnaughtan
Therapy of Metronidazole with Azathioprine to prevent postoperative recurrence of Crohn's Disease
Dr. J Macnaughtan
Mortality in Patients with and without Colectomy Admitted to Hospital for UC and Crohn's Disease
Aravinth Murugananthan, MBBS, MRCP , 27 Nov 2007
Cases from the Bigelow
Kathleen Corey, MD, MPH
Effect of Allopurinol on Clinical Outcomes in Inflammatory Bowel Disease Non-Reponders to Azathioprine and 6-Mercaptopurine
Stephen Goldfinger, M.D. , 05 Apr 2007
MMX Mesalamine in Active Ulcerative Colitis
Deanna D. Nguyen, M.D.
A Review of The CHARM Trial
Gilaad G. Kaplan, MD, MPH
The Role of the Environment in IBD
Joel V. Weinstock, M.D.
TNF-a Inhibitors in IBD
Adam S. Cheifetz, M.D.
Deanna D. Nguyen, M.D.
6. IBD related neoplasia
IBD and Lymphoma
David Weinstock, MD
Nodular Regenerative Hyperplasia in Patients with Inflammatory Bowel Disease Treated with Azathioprine
Jeremy Nightingale, MD , 12 Oct 2007
IBD and Lymphoma
David Weinstock, MD
Nodular Regenerative Hyperplasia in Patients with Inflammatory Bowel Disease Treated with Azathioprine
Jeremy Nightingale, MD , 12 Oct 2007
B. Diarrheal Disorder
1. Pathophysiology
Clostridium difficile Colitis: Pathogenesis, Diagnosis and Management
J. Thomas Lamont, M.D. , 01 Feb 2005
Causes and Treatment of Diarrhea
Stephen Goldfinger, M.D.
Colitis Other Than IBD
Gregory Y. Lauwers, M.D.
J. Thomas Lamont, M.D. , 01 Feb 2005
Causes and Treatment of Diarrhea
Stephen Goldfinger, M.D.
Colitis Other Than IBD
Gregory Y. Lauwers, M.D.
C. Geriatric Gastroenterology
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yih-Harn Siaw, MBBS, MRCP , 20 Nov 2007
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
Yih-Harn Siaw, MBBS, MRCP , 20 Nov 2007
1. Changes in GI Functioning with age
2. Common GI disorders of the elderly
Heartburn Severity Underestimates Erosive Esophagitis Severity in Elderly Patients with Gastroesophageal Reflux Disease
Alexandra Gutierrez, M.D. , 08 Apr 2004
Alexandra Gutierrez, M.D. , 08 Apr 2004
3. Age-related differences in presentation and management of GI disorders
4. Screening for GI malignancies in the elderly
5. Effect of aging on Nutrition
D. Hormones
E. Infectious Diseases
Man or Bugs: Digestive Diseases as Models for Understanding Host and Bacterial Interactions in the Genomic Era
Mark W. Babyatsky, M.D. , 27 Feb 2007
Man or Bugs: Digestive Diseases as Models for Understanding Host and Bacterial Interactions in the Genomic Era
Mark W. Babyatsky, M.D. , 27 Feb 2007
2. Viral infections in immunocompetent and immunocompromised hosts'
Bigelow Rounds
Patrick Yachimski, M.D.
Abnormal Liver Function Tests in an Immunocompromised Man in his Fifties
Helen M. Shields, M.D. , 20 Jun 2006
Patrick Yachimski, M.D.
Abnormal Liver Function Tests in an Immunocompromised Man in his Fifties
Helen M. Shields, M.D. , 20 Jun 2006
F. Motility
1. Functional Bowel Disorders
a. IBS
Managing the Somatizing Patient
Arthur Barsky, M.D. , 15 Feb 2005
Lactobacillus and Bifidobacterium in Irritable Bowel Syndrome
Elizabeth Speliotes, MD, PhD , 29 Sep 2005
Assessing Repeated Tegaserod Therapy in Women with IBS and Constipation
Elizabeth Speliotes, MD, PhD
Irritable Bowel Syndrome
Braden Kuo, M.D.
Bacterial Overgrowth in IBS: Role of Rifaximin Treatment
Peter J. Carolan, M.D. , 14 Dec 2006
The Fecal Microbiota of IBS Patients Differs from Healthy Subjects
Naila Arebi, MD, PhD , 21 Aug 2007
The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis
Philippa Youd, MBBS, MRCP , 07 Sep 2007
Colonic Pain Sensitivity in Irritable Bowel Syndrome
Dominic Bullas, MBBS, MRCP
Effect of Pregabalin on Visceral Sensation in Hypersensitive Patients with IBS
Dominic Bullas, MBBS, MRCP , 25 Sep 2007
Guidelines on the Irritable Bowel Syndrome
Shelby Webster, MBBS, MRCP , 04 Dec 2007
Arthur Barsky, M.D. , 15 Feb 2005
Elizabeth Speliotes, MD, PhD , 29 Sep 2005
Elizabeth Speliotes, MD, PhD
Irritable Bowel Syndrome
Braden Kuo, M.D.
Bacterial Overgrowth in IBS: Role of Rifaximin Treatment
Peter J. Carolan, M.D. , 14 Dec 2006
The Fecal Microbiota of IBS Patients Differs from Healthy Subjects
Naila Arebi, MD, PhD , 21 Aug 2007
The cognitive behavioural model of irritable bowel syndrome: a prospective investigation of patients with gastroenteritis
Philippa Youd, MBBS, MRCP , 07 Sep 2007
Colonic Pain Sensitivity in Irritable Bowel Syndrome
Dominic Bullas, MBBS, MRCP
Effect of Pregabalin on Visceral Sensation in Hypersensitive Patients with IBS
Dominic Bullas, MBBS, MRCP , 25 Sep 2007
Guidelines on the Irritable Bowel Syndrome
Shelby Webster, MBBS, MRCP , 04 Dec 2007
b. Physiology of GI Motility
f. Scleroderma and other major motor disorders
G. Neoplasia
1. Cancer family syndromes
HNPCC/Lynch syndrome: The Roles of MSI, IHC, and Genetic Testing
Daniel C. Chung, M.D.
Epidemiology of Colorectal Cancer
Charles S. Fuchs, MD, MPH , 01 Jun 2004
HNPCC/Lynch syndrome: The Roles of MSI, IHC, and Genetic Testing
Daniel C. Chung, M.D.
Charles S. Fuchs, MD, MPH , 01 Jun 2004
2. Nutrition and GI Cancers
3. Prevention of GI cancers
Primary Prevention of Colorectal Cancer
Andrew Chan, MD, MPH
The Effect of Age and Chronic Illness on Life Expectancy after a Diagnosis of Colorectal Cancer: Implications for Screening
Alan C. Mullen, MD, PhD , 11 Jan 2007
Prevention of Colorectal Cancer
Robert S. Sandler, MD, MPH , 16 Jan 2007
Cox-2 Inhibition and Colorectal Cancer Chemoprevention
Monica M. Bertagnolli, M.D. , 23 Jan 2007
Diet and Lifestyle: A Risk and Prognostic Factor in Colorectal Cancer
Jeffrey A. Meyerhardt, MD
Folic Acid for the Prevention of Colorectal Adenomas
Wendy Ho, M.D. , 13 Sep 2007
Andrew Chan, MD, MPH
The Effect of Age and Chronic Illness on Life Expectancy after a Diagnosis of Colorectal Cancer: Implications for Screening
Alan C. Mullen, MD, PhD , 11 Jan 2007
Prevention of Colorectal Cancer
Robert S. Sandler, MD, MPH , 16 Jan 2007
Cox-2 Inhibition and Colorectal Cancer Chemoprevention
Monica M. Bertagnolli, M.D. , 23 Jan 2007
Diet and Lifestyle: A Risk and Prognostic Factor in Colorectal Cancer
Jeffrey A. Meyerhardt, MD
Folic Acid for the Prevention of Colorectal Adenomas
Wendy Ho, M.D. , 13 Sep 2007
4. Screening for GI neoplasia
Virtual Colonoscopy
Joseph Ferrucci, M.D. , 22 Feb 2005
Primary Prevention of Colorectal Cancer
Andrew Chan, MD, MPH
Computed Tomographic Colonography: Implications for Colon Cancer Screening
Chin Hur, MD, MPH , 23 Jan 2006
Vascular Interventions in the Abdomen: New Devices and Applications
Chieh-Min Fan, M.D.
HNPCC/Lynch syndrome: The Roles of MSI, IHC, and Genetic Testing
Daniel C. Chung, M.D.
Magnetic Resonance Colonography Without Bowel Cleansing
James E. East, MBBS, MRCP
Joseph Ferrucci, M.D. , 22 Feb 2005
Andrew Chan, MD, MPH
Chin Hur, MD, MPH , 23 Jan 2006
Vascular Interventions in the Abdomen: New Devices and Applications
Chieh-Min Fan, M.D.
HNPCC/Lynch syndrome: The Roles of MSI, IHC, and Genetic Testing
Daniel C. Chung, M.D.
Magnetic Resonance Colonography Without Bowel Cleansing
James E. East, MBBS, MRCP
H. Nutrition
a. Parenteral and enteral nutritional support
Nutritional Support for Hospitalized Patients
Nancy Sceery
Randomized Trial of the Efficacy of a 2-month Tube Feeding Regimen in Anorexia Nervosa
Jeremy Nightingale, MD
Nancy Sceery
Randomized Trial of the Efficacy of a 2-month Tube Feeding Regimen in Anorexia Nervosa
Jeremy Nightingale, MD
3. Nutritional considerations in GI diseases
a. Short Gut syndrome
b. Inflammatory Bowel Disease
I. Obesity
Management of the Bariatric Patient
Lee M. Kaplan, M.D. , 29 Mar 2005
The Evolution of Severe Steatosis after Bariatric Surgery
Vincent Aguirre, MD, PhD , 27 Jul 2006
Lee M. Kaplan, M.D. , 29 Mar 2005
The Evolution of Severe Steatosis after Bariatric Surgery
Vincent Aguirre, MD, PhD , 27 Jul 2006
1. Pathophysiology, medical and surgical management of obesity
J. Pediatric GI - Age-related GI physiological and psychological variables of children and adults
2. Cystic fibrosis and GI manifestations
Cystic Fibrosis and GI Disease
Steven D. Freedman, MD, PhD , 01 Sep 2004
Pancreatitis and Primary Sclerosing Cholangitis: Targeting the Cystic Fibrosis Gene and the Brain
Steven D. Freedman, MD, PhD , 28 Mar 2006
Steven D. Freedman, MD, PhD , 01 Sep 2004
Steven D. Freedman, MD, PhD , 28 Mar 2006
3. Management of GI bleeding in Children
4. Esophagitis and Gastritis in Children
Bacterial Infections of the Intestine: Pathogenesis, Diagnosis, and Treatment
Gail Hecht, M.D.
Eosinophilic Esophagitis in Children
Stephen Goldfinger, M.D.
Gail Hecht, M.D.
Stephen Goldfinger, M.D.
5. Special considerations
K. Women's Health and GI
Eating Disorders: Evaluation and Management of the Adult Patient
Anne E. Becker, MD, PhD , 09 Jan 2007
Eating Disorders: Evaluation and Management of the Adult Patient
Anne E. Becker, MD, PhD , 09 Jan 2007
1. GI disorders in pregnancy
2. Gender differences in presentation of GI disorders
3. Complementary and alternative medicine
II.
Conditions by Organ System
A. Esophagus
1. Achalasia
2. Barrett's Esophagus
Emerging Role of Magnification Endoscopy and Chromoendoscopy
Moises Guelrud, M.D. , 17 Jan 2006
Banding Without Resection (Endoscopic Mucosal Ligation) as a Novel Approach for the Ablation of Short Segment Barrett's Epithelium
Aravinth Murugananthan, MBBS, MRCP , 27 Nov 2007
Moises Guelrud, M.D. , 17 Jan 2006
Banding Without Resection (Endoscopic Mucosal Ligation) as a Novel Approach for the Ablation of Short Segment Barrett's Epithelium
Aravinth Murugananthan, MBBS, MRCP , 27 Nov 2007
4. Esophageal dismotility
5. GERD
Plication for the Treatment of GERD: A Randomized Sham-controlled Trial
Field Willingham, MD, MPH
The Plicator: A Device Innovation Case Study
Ram Chuttani, M.D. , 04 Oct 2005
Plication for the Treatment of GERD: A Randomized Sham-controlled Trial
Field Willingham, MD, MPH
Ram Chuttani, M.D. , 04 Oct 2005
6. Esophagitis
Eosinophilic Esophagitis
Abraham L. Brass, MD, PhD
Bigelow Rounds
Patrick Yachimski, M.D.
Eosinophilic Esophagitis in Children
Stephen Goldfinger, M.D.
Characteristics of Nonerosive Reflux Disease and Reflux Esophagitis
Naila Arebi, MD, PhD
Abraham L. Brass, MD, PhD
Patrick Yachimski, M.D.
Stephen Goldfinger, M.D.
Characteristics of Nonerosive Reflux Disease and Reflux Esophagitis
Naila Arebi, MD, PhD
B. Stomach
1. Polyps and Tumors
Polyps and Tumors of the Stomach
Gregory Y. Lauwers, M.D.
Molecular Targeted Therapies and Diagnostics in GIST: Lessons Learned in Clinical Development
George D. Demetri, M.D.
Gastric Ulcer and Risk of Gastric Cancer: Is Repeat Endoscopy Necessary?
Wendy Ho, M.D.
Polyps and Tumors of the Stomach
Gregory Y. Lauwers, M.D.
Molecular Targeted Therapies and Diagnostics in GIST: Lessons Learned in Clinical Development
George D. Demetri, M.D.
Gastric Ulcer and Risk of Gastric Cancer: Is Repeat Endoscopy Necessary?
Wendy Ho, M.D.
2. Acid Peptic Disorders
The Cost-effectiveness and Budget Impact of IV versus Oral PPI in Peptic Ulcer Hemorrhage
Karin L. Andersson, M.D. , 14 Sep 2006
Gastric Acid Suppression and Risk of Oesophageal and Gastric Adenocarcinoma
Elisa K. Boden, M.D. , 16 Nov 2006
Pathology of Gastritis: Selected Cases
Gregory Y. Lauwers, M.D.
The Cost-effectiveness and Budget Impact of IV versus Oral PPI in Peptic Ulcer Hemorrhage
Karin L. Andersson, M.D. , 14 Sep 2006
Gastric Acid Suppression and Risk of Oesophageal and Gastric Adenocarcinoma
Elisa K. Boden, M.D. , 16 Nov 2006
Pathology of Gastritis: Selected Cases
Gregory Y. Lauwers, M.D.
c. H pylori
d. NSAID induced GI disorders
Pathology of Gastritis
Gregory Y. Lauwers, M.D.
Gastrointestinal Tract Injury by NSAIDs: Mechanisms of Injury and Limitations of Therapy
Byron L. Cryer, M.D.
Pathology of Gastritis
Gregory Y. Lauwers, M.D.
Gastrointestinal Tract Injury by NSAIDs: Mechanisms of Injury and Limitations of Therapy
Byron L. Cryer, M.D.
e. Indication for testing of GI secretion
3. Gastroparesis
C. Duodenum
1. Sprue
Etiologies and Predictors of Diagnosis in Nonresponsive Celiac Disease
Rakesh Chaudhary, MBBS, MRCP , 26 Jun 2007
Etiologies and Predictors of Diagnosis in Nonresponsive Celiac Disease
Rakesh Chaudhary, MBBS, MRCP , 26 Jun 2007
D. Small Intestine
1. Crohn's Disease - see General Considerations above
Infliximab Maintenance Therapy for Fistulizing Crohn’s Disease
John Evans, M.D. , 05 May 2004
Maintenance of Post-Op Crohn's Disease
Deanna D. Nguyen, M.D. , 28 Jan 2005
Controversies in the Medical Management of IBD
Stephen B. Hanauer, M.D. , 29 Nov 2005
Human anti-Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease
Deanna D. Nguyen, M.D.
TNF-a Inhibitors in IBD
Adam S. Cheifetz, M.D.
John Evans, M.D. , 05 May 2004
Deanna D. Nguyen, M.D. , 28 Jan 2005
Stephen B. Hanauer, M.D. , 29 Nov 2005
Deanna D. Nguyen, M.D.
TNF-a Inhibitors in IBD
Adam S. Cheifetz, M.D.
2. Sprue - see Duodenum, sprue
E. Colon
1. Diverticular Disease
2. Clostridial Difficile Colitis
Clostridium difficile Colitis: Pathogenesis, Diagnosis and Management
J. Thomas Lamont, M.D. , 01 Feb 2005
Effect of the Prebiotic Oligofructose on Relapse of Clostridium-difficile Associated Diarrhea - A Randomized Controlled Study
Anna Rutherford, MD, MPH , 23 Jun 2005
J. Thomas Lamont, M.D. , 01 Feb 2005
Anna Rutherford, MD, MPH , 23 Jun 2005
3. Inflammatory Bowel Disease
a. Pathophysiology of IBD
b. Genetics of IBD
c. Intestinal and nonintestinal manifestations of IBD
Human anti-Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease
Deanna D. Nguyen, M.D.
Deanna D. Nguyen, M.D.
d. IBD in pregnancy
e. Advances in IBD treatment
Infliximab Maintenance Therapy for Fistulizing Crohn’s Disease
John Evans, M.D. , 05 May 2004
Maintenance of Post-Op Crohn's Disease
Deanna D. Nguyen, M.D. , 28 Jan 2005
Controversies in the Medical Management of IBD
Stephen B. Hanauer, M.D. , 29 Nov 2005
Consult Perianal Fistula
Andrew Tai, MD, PhD
Human anti-Tumor Necrosis Factor Monoclonal Antibody (Adalimumab) in Crohn’s Disease
Deanna D. Nguyen, M.D.
Effect of Allopurinol on Clinical Outcomes in Inflammatory Bowel Disease Non-Reponders to Azathioprine and 6-Mercaptopurine
Stephen Goldfinger, M.D. , 05 Apr 2007
John Evans, M.D. , 05 May 2004
Deanna D. Nguyen, M.D. , 28 Jan 2005
Stephen B. Hanauer, M.D. , 29 Nov 2005
Andrew Tai, MD, PhD
Deanna D. Nguyen, M.D.
Effect of Allopurinol on Clinical Outcomes in Inflammatory Bowel Disease Non-Reponders to Azathioprine and 6-Mercaptopurine
Stephen Goldfinger, M.D. , 05 Apr 2007
4. Colorectal neoplasia
Colorectal Cancer Screening
Daniel C. Chung, M.D.
HNPCC/Lynch syndrome: The Roles of MSI, IHC, and Genetic Testing
Daniel C. Chung, M.D.
Villous Adenoma of the Rectum: Optimal Management
Liliana Bordeianou, M.D. , 17 Apr 2007
Colon Cancer 2006: Treatment Update
David P. Ryan, M.D.
Prevalence of Clinically Important Histology of Small Adenomas
Alexandra Gutierrez, M.D.
Computed Tomographic Colonography: Implications for Colon Cancer Screening
Chin Hur, MD, MPH , 23 Jan 2006
Primary Prevention of Colorectal Cancer
Andrew Chan, MD, MPH
Location of Adenomas Missed by Optical Colonoscopy
Lee Peng, M.D. , 03 Mar 2005
Modern Treatment of Rectal Cancer
Paul Shellito, M.D. , 11 Jan 2005
Epidemiology of Colorectal Cancer
Charles S. Fuchs, MD, MPH , 01 Jun 2004
Colorectal Cancer Screening
Daniel C. Chung, M.D.
HNPCC/Lynch syndrome: The Roles of MSI, IHC, and Genetic Testing
Daniel C. Chung, M.D.
Villous Adenoma of the Rectum: Optimal Management
Liliana Bordeianou, M.D. , 17 Apr 2007
Colon Cancer 2006: Treatment Update
David P. Ryan, M.D.
Prevalence of Clinically Important Histology of Small Adenomas
Alexandra Gutierrez, M.D.
Chin Hur, MD, MPH , 23 Jan 2006
Andrew Chan, MD, MPH
Lee Peng, M.D. , 03 Mar 2005
Paul Shellito, M.D. , 11 Jan 2005
Charles S. Fuchs, MD, MPH , 01 Jun 2004
5. Ischemia
6. Miscellaneous disorders
Long-term budesonide treatment of collagenous colitis
Dr. Sachin Gupta
Appendix Tumors: New Look at Old Problems
Joseph Misdraji, M.D. , 03 Nov 2005
Long-term budesonide treatment of collagenous colitis
Dr. Sachin Gupta
Joseph Misdraji, M.D. , 03 Nov 2005
F. Biliary
1. Evaluation of the biliary tree
2. Physiology of the biliary tract and pancreas
3. Pathology of benign and malignant biliary lesions
4. Miscellaneous biliary disorders
Photodynamic Therapy For Cholangiocarcinoma: A Light at the End of the Tunnel
Todd H. Baron, M.D. , 11 Dec 2007
Choledochal Cysts
David G. Forcione, M.D.
Abnormal Liver Function Tests in an Immunocompromised Man in his Fifties
Helen M. Shields, M.D. , 20 Jun 2006
Photodynamic Therapy For Cholangiocarcinoma: A Light at the End of the Tunnel
Todd H. Baron, M.D. , 11 Dec 2007
Choledochal Cysts
David G. Forcione, M.D.
Abnormal Liver Function Tests in an Immunocompromised Man in his Fifties
Helen M. Shields, M.D. , 20 Jun 2006
G. Pancreas
3. Pancreatitis - acute and chronic
Endoscopic versus Surgical Drainage of the Pancreatic Duct in Chronic Pancreatitis
Field Willingham, MD, MPH
RCT of IV Antioxidant Therapy in Severe Acute Pancreatitis
Dr. Adam Haycock
Endoscopic versus Surgical Drainage of the Pancreatic Duct in Chronic Pancreatitis
Field Willingham, MD, MPH
RCT of IV Antioxidant Therapy in Severe Acute Pancreatitis
Dr. Adam Haycock
4. Pancreatic neoplasia - diagnostic test, serum tumor markers, treatments
Evolving Concepts in the Understanding and Management of Cystic Neoplasms of the Pancreas
Carlos Fernandez-del Castillo, MD
Solid Pseudopapillary Tumors of The Pancreas
Deanna D. Nguyen, M.D. , 20 Sep 2005
Imaging Pancreatic Neoplasms
Dushyant Sahani, M.D.
Evolving Concepts in the Understanding and Management of Cystic Neoplasms of the Pancreas
Carlos Fernandez-del Castillo, MD
Deanna D. Nguyen, M.D. , 20 Sep 2005
Dushyant Sahani, M.D.
5. HIV associated pancreatic disorders
6. Miscellaneous pancreatic disorders
Hemosuccus Pancreaticus
Peter B. Kelsey, M.D. , 28 Oct 2004
Autoimmune Sclerosing Pancreatitis
Brenna C. Bounds, M.D.
Peter B. Kelsey, M.D. , 28 Oct 2004
Autoimmune Sclerosing Pancreatitis
Brenna C. Bounds, M.D.
H. Liver
1. Hepatic physiology
Drug Induced Liver Pathology - Part 1
Joseph Misdraji, M.D. , 06 Jul 2006
Aminotransferase Levels: what is normal?
Wolfram Goessling, MD, PhD
Cases from the Bigelow
Kathleen Corey, MD, MPH
Drug Induced Liver Pathology - Part 1
Joseph Misdraji, M.D. , 06 Jul 2006
Aminotransferase Levels: what is normal?
Wolfram Goessling, MD, PhD
Cases from the Bigelow
Kathleen Corey, MD, MPH
2. Benign and malignant hepatic lesions
Hepatic Neoplasms
Gregory Y. Lauwers, M.D. , 30 Nov 2006
Hepatocellular Carcinoma
Lawrence Blaszkowsky, M.D. , 19 Oct 2004
Cost Effectiveness of Hepatocellular Carcinoma Surveillance in Patients with Hep C related Cirrhosis
John Evans, M.D. , 03 Feb 2005
Surgical Treatment of Hepatic Malignancy Surgicaies
Martin Hertl, M.D. , 25 Oct 2005
Vascular Interventions in the Abdomen: New Devices and Applications
Chieh-Min Fan, M.D.
Hepatic Neoplasms: Clinical and Radiological Features and Optimal Management
Jonathan B. Kruskal, M.D.
Hepatic Neoplasms: Clinical and Radiological Features and Optimal Management
Sanjiv Chopra, M.D.
Hepatic Neoplasms
Gregory Y. Lauwers, M.D. , 30 Nov 2006
Lawrence Blaszkowsky, M.D. , 19 Oct 2004
John Evans, M.D. , 03 Feb 2005
Martin Hertl, M.D. , 25 Oct 2005
Vascular Interventions in the Abdomen: New Devices and Applications
Chieh-Min Fan, M.D.
Jonathan B. Kruskal, M.D.
Sanjiv Chopra, M.D.
a. Pathophysiology
Pathology of Hepatitis
Fiona M. Graeme-Cook, M.B., B.Ch. , 04 Jan 2007
Pathology Patterns in Liver Disease
Joseph Misdraji, M.D. , 04 Oct 2007
Pathology of Hepatitis
Fiona M. Graeme-Cook, M.B., B.Ch. , 04 Jan 2007
Pathology Patterns in Liver Disease
Joseph Misdraji, M.D. , 04 Oct 2007
b. Treatment
RCT of Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3
Andrew Tai, MD, PhD , 26 Jul 2007
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis
Andrew Tai, MD, PhD , 21 Jun 2007
Atorvastatin Does Not Exhibit Antiviral Activity Against HCV at Conventional Doses
Kathleen Corey, MD, MPH , 31 May 2007
Combination Therapy for Chronic Hepatitis B
Peter J. Carolan, M.D.
Management of Chronic Hepatitis B
Chinweike Ukomadu, MD, PhD , 21 Nov 2006
Entecavir for the treatment of lamivudine-refractory HBeAg-positive chronic hepatitis B
Patrick Yachimski, M.D.
An Update on Treatment of Hepatitis B
Daniel S. Pratt, M.D. , 04 Apr 2006
RCT of Peginterferon Alfa-2a and Ribavirin for 16 or 24 Weeks in HCV Genotype 2 or 3
Andrew Tai, MD, PhD , 26 Jul 2007
Sustained virological response to interferon-alpha is associated with improved outcome in HCV-related cirrhosis
Andrew Tai, MD, PhD , 21 Jun 2007
Atorvastatin Does Not Exhibit Antiviral Activity Against HCV at Conventional Doses
Kathleen Corey, MD, MPH , 31 May 2007
Combination Therapy for Chronic Hepatitis B
Peter J. Carolan, M.D.
Management of Chronic Hepatitis B
Chinweike Ukomadu, MD, PhD , 21 Nov 2006
Entecavir for the treatment of lamivudine-refractory HBeAg-positive chronic hepatitis B
Patrick Yachimski, M.D.
An Update on Treatment of Hepatitis B
Daniel S. Pratt, M.D. , 04 Apr 2006
c. Advances
6. Metabolic disorders of liver
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
Kathleen Corey, MD, MPH
Leptin Reverses Nonalcoholic Steatohepatitis in Patients with Severe Lipodystrophy
Elizabeth Speliotes, MD, PhD
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
Kathleen Corey, MD, MPH
Elizabeth Speliotes, MD, PhD
7. Hemochromatosis
Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
Jacqueline O'Leary, M.D. , 12 May 2005
Jacqueline O'Leary, M.D. , 12 May 2005
8. Ischemic liver injury
9. Fulminant hepatic failure
10. Complications of chronic liver disease: Portal hypertension
Antibiotic Prophylaxis After Endoscopic Therapy Prevents Rebleeding in Acute Variceal Hemorrhage: A Randomized Trial
Anna Rutherford, MD, MPH , 05 May 2004
Portal Hypertension and Variceal Hemorrhage
Norman Grace, M.D. , 22 Nov 2005
Cirrhosis and Complications of Chronic Liver Disease
Raymond T. Chung, M.D.
Vascular Interventions in the Abdomen: New Devices and Applications
Chieh-Min Fan, M.D.
Non Invasive Markers of Portal Hypertension
Amir A. Qamar, M.D. , 26 Jun 2007
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
Siew Ng, MBBS, MRCP , 27 Nov 2007
Anna Rutherford, MD, MPH , 05 May 2004
Norman Grace, M.D. , 22 Nov 2005
Cirrhosis and Complications of Chronic Liver Disease
Raymond T. Chung, M.D.
Vascular Interventions in the Abdomen: New Devices and Applications
Chieh-Min Fan, M.D.
Non Invasive Markers of Portal Hypertension
Amir A. Qamar, M.D. , 26 Jun 2007
Primary Prophylaxis of Spontaneous Bacterial Peritonitis Delays Hepatorenal Syndrome and Improves Survival in Cirrhosis
Siew Ng, MBBS, MRCP , 27 Nov 2007
11. Gallstone disease
13. Hepatic pathology
14. Surgical risk stratification in patients with liver disease
Surgery in the Patient with Liver Disease
Lawrence S. Friedman, M.D.
Surgery in the Patient with Liver Disease
Lawrence S. Friedman, M.D.
Surgery in the Patient with Liver Disease
Lawrence S. Friedman, M.D.
Lawrence S. Friedman, M.D.
15. Autoimmune liver disease
Autoimmune Hepatitis
Andrea E. Reid, MD, MPH , 10 May 2005
Autoantibodies in Liver Disease
Edward Krawitt, M.D.
Andrea E. Reid, MD, MPH , 10 May 2005
Edward Krawitt, M.D.
16. Cholestatic liver disease
PBC: Clinical Update
Daniel S. Pratt, M.D. , 19 Sep 2006
Update on PBC and PSC
Daniel S. Pratt, M.D. , 08 Mar 2005
Pancreatitis and Primary Sclerosing Cholangitis: Targeting the Cystic Fibrosis Gene and the Brain
Steven D. Freedman, MD, PhD , 28 Mar 2006
Antinuclear Antibody in PBC and Liver Failure Risk
Anna Rutherford, MD, MPH , 10 Feb 2005
PBC: Clinical Update
Daniel S. Pratt, M.D. , 19 Sep 2006
Daniel S. Pratt, M.D. , 08 Mar 2005
Steven D. Freedman, MD, PhD , 28 Mar 2006
Anna Rutherford, MD, MPH , 10 Feb 2005
17. Drug hepatotoxicity
Hepatotoxicity and HAART
Barbara McGovern, M.D.
Drug-Induced Hepatotoxicity: Results from the Acute Liver Failure Study Group
William M. Lee, M.D. , 21 Mar 2006
Drug Induced Liver Pathology - Part 1
Joseph Misdraji, M.D. , 06 Jul 2006
Barbara McGovern, M.D.
William M. Lee, M.D. , 21 Mar 2006
Drug Induced Liver Pathology - Part 1
Joseph Misdraji, M.D. , 06 Jul 2006
18. NAFLD
Leptin Reverses Nonalcoholic Steatohepatitis in Patients with Severe Lipodystrophy
Elizabeth Speliotes, MD, PhD
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
Kathleen Corey, MD, MPH
Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan
Elizabeth Speliotes, MD, PhD , 28 Sep 2006
Elizabeth Speliotes, MD, PhD
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis
Kathleen Corey, MD, MPH
Prevalence and Risk Factors of Nonalcoholic Fatty Liver Disease in an Adult Population of Taiwan
Elizabeth Speliotes, MD, PhD , 28 Sep 2006
III.
Interventions in Gastroenterology
A. EGD
The Utility of Upper Endoscopy in Patients with Concomitant Upper Gastrointestinal Bleeding and Acute Myocardial Infarction
Karin L. Andersson, M.D. , 25 Jan 2007
The Utility of Upper Endoscopy in Patients with Concomitant Upper Gastrointestinal Bleeding and Acute Myocardial Infarction
Karin L. Andersson, M.D. , 25 Jan 2007
1. Management of Upper GI bleeding
Endoscopic clipping versus injection and thermo-coagulation in non-variceal upper GI bleeding
Meron Jacyna, MD
Effect of Scheduled Second Therapeutic Endoscopy on Peptic Ulcer Rebleeding: A Prospective Randomised Trial
Lee Peng, M.D. , 15 Apr 2004
The Utility of Upper Endoscopy in Patients with Concomitant Upper Gastrointestinal Bleeding and Acute Myocardial Infarction
Karin L. Andersson, M.D. , 25 Jan 2007
Omeprazole Before Endoscopy in Patients with Gastrointestinal Bleeding
Field Willingham, MD, MPH
Endoscopic clipping versus injection and thermo-coagulation in non-variceal upper GI bleeding
Meron Jacyna, MD
Lee Peng, M.D. , 15 Apr 2004
The Utility of Upper Endoscopy in Patients with Concomitant Upper Gastrointestinal Bleeding and Acute Myocardial Infarction
Karin L. Andersson, M.D. , 25 Jan 2007
Omeprazole Before Endoscopy in Patients with Gastrointestinal Bleeding
Field Willingham, MD, MPH
2. Endoscopic management of GERD
Plication for the Treatment of GERD: A Randomized Sham-controlled Trial
Field Willingham, MD, MPH
A New Frontier in Gastroenterology - Expanded Applications of Flexible Endoscopy
Christopher C. Thompson, M.D. , 08 Feb 2005
Heartburn Severity Underestimates Erosive Esophagitis Severity in Elderly Patients with Gastroesophageal Reflux Disease
Alexandra Gutierrez, M.D. , 08 Apr 2004
The Plicator: A Device Innovation Case Study
Ram Chuttani, M.D. , 04 Oct 2005
Plication for the Treatment of GERD: A Randomized Sham-controlled Trial
Field Willingham, MD, MPH
Christopher C. Thompson, M.D. , 08 Feb 2005
Alexandra Gutierrez, M.D. , 08 Apr 2004
Ram Chuttani, M.D. , 04 Oct 2005
B. ERCP
Review of EUS and ERCP
William R. Brugge, M.D. , 10 Apr 2007
ERCP Review
Robert H. Schapiro, M.D. , 12 Jun 2007
Cholecystectomy or Not After ERCP and Sphincterotomy
Wendy Ho, M.D.
Review of EUS and ERCP
William R. Brugge, M.D. , 10 Apr 2007
ERCP Review
Robert H. Schapiro, M.D. , 12 Jun 2007
Cholecystectomy or Not After ERCP and Sphincterotomy
Wendy Ho, M.D.
1. Indications and limitations of ERCP
Cholecystectomy or Not After ERCP and Sphincterotomy
Wendy Ho, M.D.
Endoscopic versus Surgical Drainage of the Pancreatic Duct in Chronic Pancreatitis
Field Willingham, MD, MPH
ERCP Review
Robert H. Schapiro, M.D. , 12 Jun 2007
Cholecystectomy or Not After ERCP and Sphincterotomy
Wendy Ho, M.D.
Endoscopic versus Surgical Drainage of the Pancreatic Duct in Chronic Pancreatitis
Field Willingham, MD, MPH
ERCP Review
Robert H. Schapiro, M.D. , 12 Jun 2007
C. Colon
Colonoscopic Withdrawal Times and Adenoma Detection during Screening Colonoscopy
Elizabeth Speliotes, MD, PhD
Chromoscopy-Guided Endomicroscopy
Patrick Yachimski, M.D. , 19 Apr 2007
High Yields of Small and Flat Adenomas with High-Definition Colonoscopes Using Either White Light or NBI
James E. East, MBBS, MRCP
Epinephrine Volume Reduction of Giant Colon Polyps Facilitates Endoscopic Assessment and Removal
Dr. Adam Haycock , 11 Oct 2007
CT Colonography versus Colonoscopy for the Detection of Advanced Neoplasia
Alan C. Mullen, MD, PhD
Double-balloon Colonoscopy After Failed Conventional Colonoscopy
Aymer Postgate, MBBS, MRCP , 08 Nov 2007
CT Colonography versus Colonoscopy for the Detection of Advanced Neoplasia
Aymer Postgate, MBBS, MRCP , 08 Nov 2007
Colonoscopic Withdrawal Times and Adenoma Detection during Screening Colonoscopy
Elizabeth Speliotes, MD, PhD
Chromoscopy-Guided Endomicroscopy
Patrick Yachimski, M.D. , 19 Apr 2007
High Yields of Small and Flat Adenomas with High-Definition Colonoscopes Using Either White Light or NBI
James E. East, MBBS, MRCP
Epinephrine Volume Reduction of Giant Colon Polyps Facilitates Endoscopic Assessment and Removal
Dr. Adam Haycock , 11 Oct 2007
CT Colonography versus Colonoscopy for the Detection of Advanced Neoplasia
Alan C. Mullen, MD, PhD
Double-balloon Colonoscopy After Failed Conventional Colonoscopy
Aymer Postgate, MBBS, MRCP , 08 Nov 2007
CT Colonography versus Colonoscopy for the Detection of Advanced Neoplasia
Aymer Postgate, MBBS, MRCP , 08 Nov 2007
D. GI Rads
Pathology of Pancreatic Cystic Neoplasms
Gregory Y. Lauwers, M.D. , 06 Oct 2005
Computed Tomographic Colonography: Implications for Colon Cancer Screening
Chin Hur, MD, MPH , 23 Jan 2006
Vascular Interventions in the Abdomen: New Devices and Applications
Chieh-Min Fan, M.D.
Gregory Y. Lauwers, M.D. , 06 Oct 2005
Chin Hur, MD, MPH , 23 Jan 2006
Vascular Interventions in the Abdomen: New Devices and Applications
Chieh-Min Fan, M.D.
E. GI Surgery - Specific surgical techniques
1. Antireflux surgery
2. Ulcer surgery
3. Hepatobiliary operations
4. Surgery for IBD
5. Diverticular surgery
6. Stomas
IV.
Issues in Gastroenterology Training
B. Core curriculum
